Skip to main navigation Skip to search Skip to main content

Bevacizumab therapy normalizes the pathological intraocular environment beyond neutralizing VEGF

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2175-2184
Number of pages10
JournalMolecular Vision
Volume16
StatePublished - 2010

ASJC Scopus Subject Areas

  • Ophthalmology

Cite this